Novavax Booster Approved: Adults 18+ – CDC Update
- Adults now have another option for COVID-19 protection. The Centers for Disease Control and Prevention (CDC) has authorized Novavax monovalent COVID-19 boosters for adult use.
- The Novavax COVID-19 boosters are designed to target current variants, offering enhanced protection. This approval marks a significant step in ongoing efforts to combat the virus and provide...
- Distribution of the Novavax boosters is expected to begin soon.
The CDC has just approved Novavax monovalent COVID-19 boosters for adults aged 18 and over, providing another layer of defense against the evolving virus. This crucial decision, signed off by CDC Director Rochelle P. Walensky, expands the range of COVID-19 vaccine options available to the public.The new Novavax COVID-19 boosters are specifically formulated to combat current variants, delivering enhanced protection and presenting additional booster options. As News Directory 3 informs, the rollout is imminent. Consult your healthcare provider to explore if this is right for you.Discover what’s next regarding improved COVID-19 protection.
Novavax COVID-19 Boosters Approved for Adults
Updated June 08,2025
Adults now have another option for COVID-19 protection. The Centers for Disease Control and Prevention (CDC) has authorized Novavax monovalent COVID-19 boosters for adult use. This decision, formalized in a memo signed by CDC Director Rochelle P. Walensky, expands the availability of COVID-19 vaccine options.
The Novavax COVID-19 boosters are designed to target current variants, offering enhanced protection. This approval marks a significant step in ongoing efforts to combat the virus and provide diverse booster options for the public.
What’s next
Distribution of the Novavax boosters is expected to begin soon. Individuals seeking a booster should consult with their healthcare provider to determine the best course of action.